Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
- 1 May 2019
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 156 (6), 1683-1692.e1
- https://doi.org/10.1053/j.gastro.2019.01.027
Abstract
No abstract availableKeywords
Funding Information
- Sirtex Medical (R01 CA222900)
- AbbVie (R01 CA222900)
- National Cancer Institute (R01 CA222900)
- Bayer Fund (R01 CA222900)
- Gilead Sciences (R01 CA222900)
- AbbVie (R01 CA222900)
This publication has 29 references indexed in Scilit:
- Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolutionJournal of Hepatology, 2016
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antiviralsJournal of Hepatology, 2016
- Recurrence of Hepatocellular Cancer After ResectionAnnals of Surgery, 2015
- Optimal Imaging Surveillance Schedules after Liver-Directed Therapy for Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2015
- Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical OutcomeAnnals of Surgical Oncology, 2013
- Hepatitis C in the United StatesThe New England Journal of Medicine, 2013
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic FactorsThe American Journal of Gastroenterology, 2012
- Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic ReviewJournal of General Internal Medicine, 2012
- A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C VirusClinical Gastroenterology and Hepatology, 2010